Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences